Most cases of myocarditis have been reported among Israelis under the age of 30, the Ministry of Health said.
In Israel, dozens of cases of heart inflammation have been detected among more than 5 million people vaccinated against coronavirus, mainly after the second dose of the drug from Pfizer. This is reported by Reuters with reference to the Israeli Ministry of Health on Monday, April 26.
- Nutritionist reveals the danger of brown bread
- Experts find a treatment for women with ‘Angelina Jolie gene’
- This is the worst companion for your cup of coffee
- Omega 3 could hold key for delivering drugs to the brain
- Sen. Schumer urges to include dental, hearing, vision to healthcare in President Biden’s infrastructure plan
“The Health Ministry is currently examining whether there is an excess in morbidity (disease rate) and whether it can be attributed to the vaccines,” said Nachman Ash, Israel’s pandemic program coordinator, adding that no conclusions have been drawn so far.
According to him, most cases of myocarditis are registered among people under the age of 30. However, it will be difficult to determine the link between heart disease and vaccination, because myocarditis can be caused by various viruses. A similar number of cases of heart inflammation have been reported in previous years, Nachman Ash added.
Pfizer said it is in regular contact with the Israeli Ministry of Health to verify the data on its vaccine. In particular, the company said it was “aware of Israeli observations of myocarditis, which occurred primarily among young people who received the Pfizer-BioNTech COVID-19 vaccine.”
As you know, Israel is one of the world leaders in vaccination against coronavirus. More than 5.3 million people received the first dose of the vaccine, and 5 million people received the second dose.
Fully vaccinated about 54% of the country’s population and about 74% of the adult population (over 16 years old).